Clarithromycin: all 173 studies that test it

Page 2 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple MyelomaActive, not recruitingNCT02542657Phase 1/2
• Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter PyloriStatus unknownNCT02422706Phase 3
• Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?TerminatedNCT02416570Phase 2
• First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCLStatus unknownNCT02388581Phase 2
• A Study to Evaluate the Absolute Bioavailability of Intranasal and Oral Esketamine and the Effects of Clarithromycin on the Pharmacokinetics of Intranasal Esketamine in Healthy ParticipantsCompletedNCT02343289Phase 1
• Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of DeflazacortCompletedNCT02286635Phase 1
• Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of TipranavirCompletedNCT02251769Phase 1
• Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple MyelomaStatus unknownNCT02248428Phase 3
• A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male ParticipantsCompletedNCT02197884Phase 1
• Bioavailability of Dabigatran With or Without Clarithromycin in Healthy VolunteersCompletedNCT02171585Phase 1
• Drug-Drug Interaction Study Between CJ-12420 and Clarithromycin in Healthy Male SubjectsCompletedNCT02052336Phase 1
• Concomitant Therapy of H. PyloriStatus unknownNCT01922765Phase 4
• The PK and PD Interaction Between YH4808, Amoxicillin and Clarithromycin in Healthy SubjectsCompletedNCT01921647Phase 1
• 15-day Sequential Therapy for Helicobacter Pylori Infection in KoreaCompletedNCT01887249Phase 4
• Pharmacokinetic Study of Clarithromycin in Very Low Birth Weight (VLBW)TerminatedNCT01851954Phase 2
• WHO Drug Study for Buruli Ulcer - Comparison of SR8 and CR8CompletedNCT01659437Phase 2/3
• Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone LymphomaCompletedNCT01516606Phase 2
• Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of MembraneCompletedNCT01503606Phase 3
• 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori EradicationStatus unknownNCT01464060Phase 4
• Antibiotics Study in Preterm Premature Rupture of the MembranesCompletedNCT01401179Phase 3
• Treatment of Mycobacterium Xenopi Pulmonary InfectionCompletedNCT01298336Phase 3
• CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
• Study Comparing Sequential and Concomitant Therapy for Helicobacter Pylori Eradication in Routine Clinical PracticeCompletedNCT01273441Phase 4
• Clarithromycin as Immunomodulator for the Management of SepsisCompletedNCT01223690Phase 3
• A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori InfectionCompletedNCT01219764Phase 4
• Persistent Lyme Empiric Antibiotic Study EuropeCompletedNCT01207739Phase 4
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
• To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting ConditionsCompletedNCT00881738Phase 1
• To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting ConditionsCompletedNCT00881179Phase 1
• Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired PneumoniaCompletedNCT00818610Phase 4
• Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed ConditionsCompletedNCT00775372Not applicable
• Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting ConditionsCompletedNCT00775255Not applicable
• Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting ConditionsCompletedNCT00774696Not applicable
• Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.CompletedNCT00774644Not applicable
• Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting ConditionsCompletedNCT00774189Phase 1
• Effect of Eradication of Helicobacter Pylori on the Dyspeptic SymptomsCompletedNCT00772837Not applicable
• Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in ColombiaCompletedNCT00719420Phase 3
• Study of the Ability of Clarithromycin to Induce Oxidative StressCompletedNCT00707330Phase 1
• Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting StateCompletedNCT00648960Phase 1
• Comparative Bioavailability Study of Clarithromycin 250 mg TabletsCompletedNCT00648830Phase 1
• Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed StateCompletedNCT00648128Phase 1
• Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic BronchitisCompletedNCT00645086Phase 3
• Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial SinusitisCompletedNCT00644553Phase 3
• A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult PatientsCompletedNCT00643227Phase 3
• Bioequivalency Study of Clarithromycin Tablets Under Fed ConditionsCompletedNCT00602498Not applicable
• Bioequivalency Study of Clarithromycin Tablets Under Fasting ConditionsCompletedNCT00601315Not applicable
• Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)CompletedNCT00600769Phase 4
• Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung DiseaseCompletedNCT00598897Phase 4
• Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of TherapyWithdrawnNCT00475527Phase 4
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNCT00467571Phase 4
• Use of Clarithromycin in Mustard-Induced BronchiolitisCompletedNCT00381147Phase 3
• Chronic Bronchiolitis or Resistant Asthma?CompletedNCT00368342Phase 4
• Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment OutcomeCompletedNCT00327132Not applicable
• Intravenous Clarithromycin in Septic SyndromeCompletedNCT00297674Phase 4
• Clarithromycin in Active Crohn's DiseaseCompletedNCT00269386Phase 3
• Outpatient Registry Trial of Respiratory Tract Infections in AdultsWithdrawnNCT00245453Phase 4
• Macrolide Antibiotic Therapy for Patients With Cystic FibrosisCompletedNCT00205634Phase 2
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3
• Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With TransplantCompletedNCT00182663Phase 2
• Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple MyelomaCompletedNCT00151203Phase 2
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3
• The CLARICOR Trial: Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart DiseaseCompletedNCT00121550Phase 3
• Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the StomachCompletedNCT00002682Phase 2
• The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNCT00002336Not applicable
• The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDSCompletedNCT00002331Not applicable
• An Open-Label Study in HIV+ Patients to Determine the Effects of Nevirapine (Viramune) on the Pharmacokinetics of Clarithromycin and Activity of Cytochrome 3A4.CompletedNCT00002194Phase 1
• A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs PatientsCompletedNCT00002140Phase 3
• A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or PlaceboCompletedNCT00002101Phase 3
• A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDSCompletedNCT00001058Phase 2
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedNCT00001030Phase 3
• The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected PatientsCompletedNCT00001023Not applicable
• The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDSCompletedNCT00000971Phase 1
• A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDSCompletedNCT00000644Phase 2

← Clarithromycin overview